Imaging of the β-cells of the islets of Langerhans

Diabetes Research and Clinical Practice

Volumn 98, Issue 1, 2012, Pages 11-18

  Malaisse, Willy J ^a   Maedler, Kathrin ^b  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITY OF BREMEN   (Germany)

Author keywords

Diabetes mellitus; Non invasive imaging; Pancreatic islet cells

Indexed keywords

4 FLUOROBENZYLTROZAMICAL F 18; DEHYDROTETRABENAZINE C 11; FALLYPRIDE F 18; GLIBENCLAMIDE; GLIBENCLAMIDE C 11; GLIBENCLAMIDE F 18; GLIBENCLAMIDE TC 99M; MANGANESE; MANNOHEPTULOSE; NANOPARTICLE; NEUROHORMONE; RADIOISOTOPE; REPAGLINIDE; REPAGLINIDE C 11; REPAGLINIDE F 18; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; ZINC;

ANTERIOR EYE CHAMBER; BIOLUMINESCENCE; CELL ACTIVITY; CELL FUNCTION; DIABETES MELLITUS; EMBRYONIC STEM CELL; HUMAN; IMAGE ANALYSIS; IN VIVO STUDY; MOLECULAR IMAGING; MULTIPHOTON MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET BETA CELL; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MAGNETIC RESONANCE IMAGING; MALE; MANNOHEPTULOSE; NANOPARTICLES; OPTICAL IMAGING; SULFONYLUREA COMPOUNDS;

EID: 84867402753     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2012.07.001     Document Type: Review

References (82)

1. Malaisse W.J. On the track to the β-cell. Diabetologia 2001, 44:393-406.
2. Malaisse W.J. Non-invasive imaging of the endocrine pancreas. Int J Mol Med 2005, 15:243-246.
3. Paty B.W., Bonner-Weir S., Laughlin M.R., McEwan A.J., Shapiro A.M. Toward development of imaging modalities for islet after transplantation: insights from the National Institutes of Health Workshop on β cell imaging. Transplantation 2004, 77:1133-1137.
4. Souza F., Freeby M., Hultman K., Simpson N., Herron A., Witkowsky P., et al. Current progress in non-invasive imaging of β cell mass of the endocrine pancreas. Curr Med Chem 2006, 13:2761-2773.
5. Lin M., Lubag A., McGuire M.J., Seliounine S.Y., Tsygenov E.N., Antich P.P., et al. Advances in molecular imaging of pancreatic β cells. Front Biosci 2008, 13:4558-4575.
6. Saudek F., Brogren C.H., Manohar S. Imaging the β-cell mass: why and how. Rev Diabet Stud 2008, 5:6-12.
7. Holmberg D., Ahlgren U. Imaging the pancreas: from ex vivo to non-invasive technology. Diabetologia 2008, 51:2148-2154.
8. Medarova Z., Moore A. Non-invasive detection of transplanted pancreatic islets. Diabetes Obes Metab 2008, 10(Suppl. 4):88-97.
9. Malaisse W.J., Louchami K., Sener A. Non-invasive imaging of pancreatic β-cells. Nat Rev Endocrinol 2009, 5:394-400.
10. Medarova Z., Moore A. MRI in diabetes: first results. Am J Roentgenol 2009, 193:295-303.
11. Brom M., Aldraojć K., Oyen W.J.G., Boerman O.C., Gotthardt M. Development of radiotracers for the determination of beta-cell mass in vivo. Curr Pharm Des 2010, 16:1561-1567.
12. Leoni L., Roman B.B. MR imaging of pancreatic islets: tracking isolation, transplantation and function. Curr Pharm Des 2010, 16:1582-1594.
13. Arifin D.R., Bulte J.W.M. Imaging of the pancreatic islet cells. Diab Metab Res Rev 2011, 27:761-766.
14. Wang P., Medarova Z., Moore A. Molecular imaging: a promising tool to monitor islet transplantation. J Transplant 2001, 2011:ID202915.
15. Sweet I.R., Cook L., Lernmark A., Greenbaum C.J., Krohn K.A. Non-invasive imaging of β cell mass: a quantitative analysis. Diabetes Technol Ther 2004, 6:625-629.
16. 125I]iodo-d-glucose. In vivo experiments. Endocrine 2000, 13:95-101.
17. 14C]alloxan. Int J Mol Med 2001, 7:311-351.
18. Malaisse W.J., Courtois P., Kadiata M.M., Sener A. GLUT2-mediated transport of d-mannoheptulose: a tool for imaging of the endocrine pancreas?. Diabetes 2000, 49(Suppl. 1):A418.
19. 3H]mannoheptulose. Am J Physiol 2001, 281:E293-E303.
20. 19F-heptuloses as tools for the non-invasive imaging of GLUT2-expressing cells. Arch Biochem Biophys 2012, 517:138-143.
21. Schneider S., Feilen P.J., Schreckenberger M., Schwanstecher M., Schwanstecher C., Buchholz H.G., et al. In vitro and in vivo evaluation of novel glibenclamide derivatives as imaging agents for the non-invasive assessment of the pancreatic islet cell mass in animals and humans. Exp Clin Endocrinol Diab 2005, 113:388-393.
22. 11C]methoxy-repaglinide): a potential beta-cell imaging agent. Bioorg Med Chem Lett 2004, 14:5205-5209.
23. 18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET). Nucl Med Biol 2004, 31:639-647.
24. 18F]4-fluorobenzyltrozamicol. Eur J Nucl Med Mol Imaging 2004, 31:258-260.
25. 18F-fallypride PET of pancreatic islets: in vitro and in vivo rodent studies. J Nucl Med 2011, 52:1125-1132.
26. 11C-dihydrotetrabenazine PET: a perspective. J. Nucl Med 2009, 50:335-337.
27. Tsao H.-H., Lin K.-J., Juang J.-H., Skovronsky D.M., Yen T.-C., Wey S.P., et al. Binding characteristics of 9-fluoropropyl-(+)-dihydrotetrabenazine (AV-133) to the vesicular monoamine transporter type 2 in rats. Nucl Med Biol 2010, 37:413-419.
28. 11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls. J Nucl Med 2009, 50:382-389.
29. Amartey J.K., Esguerra C., Al-Jammaz I., Parhar R.S., Al-Otabi B. Synthesis and evaluation of radioiodinated substituted β-naphthylalanine as a potential probe for pancreatic β-cells imaging. Appl Radiat Isot 2006, 64:769-777.
30. Mikkola K., Ishizu I., Nuutila P., Fagerholm V. Labelling of pancreatic islets with α2-adrenoceptor, M3 muscarinic receptor and dopamine D2 receptor ligands in rodents. Abstracts annual congress of the European association of nuclear medicine 2001, OP531.
31. 64Cu]-MAN-EXENDIN-4(9-39) via site-specific prelabelling. J Labell Compd Rad 2009, 52:72.
32. 68Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET. Eur J Nucl Med Mol Imaging 2010, 37:1345-1355.
33. Reiner T., Thurber G., Gaglia J., Vinegoni C., Liew C.W., Upadhyay R., et al. Accurate measurement of pancreatic islet β-cell mass using a second-generation fluorescent exendin-4 analog. Proc Natl Acad Sci USA 2011, 108:12815-12820.
34. Barnett B.P., Ruiz-Cobello J., Hota P., Ouwerkerk R., Shamblott M.J., Lauzon C., et al. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. Contrast Media Mol Imaging 2011, 6:251-259.
35. Chan K.M., Raikwar S.P., Zevozava N. Strategies for differentiating embryonic stem cells (ESC) into insulin-producing cells and development of non-invasive imaging techniques using bioluminescence. Immunol Res 2007, 39:261-270.
36. Raikwar S.P., Zavazava N. Real-time non-invasive imaging of ES cells-derived insulin-producing cells. Methods Mol Biol 2009, 599:317-334.
37. + T-cells to the pancreas in real time. Diabetes 2004, 53:1459-1466.
38. Turvey S.E., Swart E., Denis M.C., Mahmood U., Benoist C., Weissleder R., et al. Noninvasive imaging of pancreatic inflammation and its reversal in type 1 diabetes. J Clin Invest 2005, 115:2454-2461.
39. Park S.Y., Wang X., Chen Z., Powers A.C., Magnusson M.A., Head W.S., et al. Optical imaging of pancreatic beta cells in living mice expressing a mouse insulin I promoter-firefly fluciferase transgene. Genesis 2005, 43:80-86.
40. Smith S.J., Zhang H., Clermont A.O., Powers A.C., Kaufman D.B., Purchio A.F., et al. In vivo monitoring of pancreatic beta-cells in a transgenic mouse model. Mol Imaging 2006, 5:65-75.
41. Martinic M.M., von Herrath M.G. Real-time imaging of the pancreas during development of diabetes. Immunol Rev 2009, 221:200-213.
42. Speier S., Nyqvist D., Cabrera O., Yu J., Molano R.D., Pileggi A., et al. Noninvisave in vivo imaging of pancreatic islet cell biology. Nat Med 2008, 14:547-578.
43. Alanentalo T., Asayesh A., Morrison H., Lorén C.E., Holmberg D., Sharpe J., et al. Tomographic molecular imaging and 3D quantification within adult mouse organs. Nat Methods 2007, 4:31-33.
44. Villiger M., Goulley J., Friedrich M., Grapin-Bottom A., Meda P., Lasser T., et al. In vivo imaging of murine endocrine islets of Langerhans with extended-focus optical coherence microscopy. Diabetologia 2009, 52:1599-1607.
45. Bogren C.-H., Hirsch F., Wood P., Druet P., Poussier P. Production and characterization of a monoclonal islet cell surface autoantibody from the BB rat. Diabetologia 1986, 29:330-333.
46. Hutton J.C., Davidson H.W. Getting beta all the time: discovery of reliable markers of beta cell mass. Diabetologia 2010, 53:1254-1257.
47. Flamez D., Roland I., Berton A., Kutlu B., Dufrane D., Beckers M.C., et al. A genomic-based approach identifies FXYD domain containing ion transport regulator 2 (FXYD2)γa as a pancreatic beta cell-specific biomarker. Diabetologia 2010, 53:1372-1383.
48. Ueberbeg S., Ziegler D., Schechinger W., Dietrich J.W., Akinturk S., Klein H.H., et al. In vitro phage display in rat beta cell line: a simple approach for the generation of a single-chain antibody targeting a novel beta cell-specific epitope. Diabetologia 2010, 53:1384-1394.
49. Bouckenooghe T., Flamez D., Ortis F., Goldman S., Eizirik D.L. Identification of new pancreatic beta cell targets for in vivo imaging by a systems biology approach. Curr Pharm Des 2010, 16:1609-1618.
50. 89Zr-labeled monoclonal antibodies. J Nucl Med 2003, 44:1271-1281.
51. Perk L.R., Vosjan M.J.W.D., Visser G.W.M., Budde M., Jurek P., Kiefer G.E., et al. p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging. Eur J Nucl Med Mol Imaging 2010, 37:250-259.
52. Vosjan M.J.W.D., Perk L.R., Visser G.W.M., Budde M., Jurek P., Kiefer G.E., et al. Conjugation and radiolabeling of monoclonal antibodies with zirconium-99 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine. Nat Protocols 2010, 5:739-743.
53. van Dongen G.A.M.S., Vosjan M.J.W.D. Immuno-positron emission tomographyl shedding light on clinical antibody therapy. Cancer Biother Radiopharm 2010, 25:375-385.
54. Olafsen T., Wu A.M. Antibody vectors for imaging. Semin Nucl Med 2010, 20:167-181.
55. Leibiger I.B., Caiceo A., Berggren P.-O. Non-invasive in vivo imaging of pancreatic β-cell function and survival - a perspective. Acta Physiol 2012, 204:178-185.
56. Brockenbrough J.S., Weir G.C., Bonner-Weir S. Discordance or exocrine and endocrine growth after 90% pancreatectomy in rats. Diabetes 1988, 37:232-236.
57. Matveyenko A.V., Veldhuis J.D., Butler P.C. Adaptations in pulsatile insulin secretion, hepatic insulin clearance, and beta-cell mass to age-related insulin resistance in rats. Am J Physiol Endocrinol Metab 2008, 295:E832-E841.
58. Ritzel R.A., Butler A.E., Rizza R.A., Veldhuis J.D., Butler P.C. Relationship between beta-cell mass and fasting blood glucose concentration in humans. Diabetes Care 2006, 29:717-718.
59. Saisho Y., Butler A.E., Manesso E., Galasso R., Zhang L., Gurlo T., et al. Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys. Diabetologia 2010, 53:111-114.
60. Matveyenko A.V., Butler P.C. Relationship between beta-cell mass and diabetes onset. Diabetes Obes Metab 2008, 10(Suppl. 4):23-31.
61. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
62. Meier J.J., Breuer T.G.K., Bonadonna R.C., Tannapfel A., Uhl W., Schmidt W.E., et al. Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans. Diabetologia 2012, 55:1346-1354.
63. Brisson G.R., Malaisse-Lagae F., Malaisse W.J. The stimuls-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine-3'-5'-cyclic monophosphate. J Clin Invest 1972, 51:232-241.
64. 2+ oscillations in glucose-stimulated pancreatic beta-cells. Am J Physiol 1999, 276:E512-E518.
65. Rorsman P., Hellman B. The interaction between manganese and calcium fluxes in pancreatic beta-cells. Biochem J 1983, 210:307-314.
66. Gimi B., Leoni L., Oberholzer J., Braum M., Avila J., Wang Y., et al. Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant 2006, 15:195-203.
67. Mendonca-Dias M.H., Gaggelli E., Lauterbur P.C. Paramagnetic contrast agents in nuclear magnetic resonance medical imaging. Semin Nucl Med 1983, 13:364-376.
68. Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann NY Acad Sci 2004, 1012:115-128.
69. Olanow C.W. Manganese-induced parkinsonism and Parkinson's disease. Ann NY Acad Sci 2004, 1012:209-223.
70. Roth J.A., Garrick M.D. Iron interactions and other biological reactions mediating the physiological and toxic actions of manganese. Biochem Pharmacol 2003, 66:1-13.
71. Latchoumycandane C., Anantharam V., Kitazawa M., Yang Y., Kanthasamy A., Kanthasamy A.G. Protein kinase Cdelta is a key downstream mediator of manganese-induced apoptosis in dopaminergic neuronal cells. J Pharmacol Exp Ther 2005, 313:46-55.
72. Silva A.C., Lee J.H., Aoki I., Koretsky A.P. Manganese-enhanced magnetic resonance imaging (MEMRI): methodological and practical considerations. NMR Biomed 2004, 17:532-543.
73. Antkowiak P.F., Vandsburger M.H., Epstein F.H. Quantitative pancreatic β cell MRI using manganese-enhanced look-locker imaging and two-site water exchange analysis. Magn Reson Med 2012, 67:1730-1739. 10.1002/rmn.23139.
74. Lamprianou S., Immonen R., Nabuurs C., Gjinovci A., Vinet L., Montet X.C.R., et al. High-resolution magnetic resonance imaging quantitatively detects individual pancreatic islets. Diabetes 2011, 60:2853-2860.
75. Watanabe T., Frahm J., Michaelis T. Myelin mapping in the living mouse brain using manganese-enhanced magnetization transfer. MRI Neuroimage 2010, 49:1200-1204.
76. Bertin A., Michou-Gallani A.I., Gallani J.L., Felder-Flesch D. In vitro neurotoxicity of magnetic resonance imaging (MRI) contrast agents: influence of the molecular structure and paramagnetic ion. Toxicol In Vitro 2010, 24:1386-1394.
77. Gehl H.B., Vorwerk D., Klose K.C., Gunther R.W. Pancreatic enhancement after low-dose infusion of Mn-DPDP. Radiology 1991, 180:337-339.
78. Gong J., Xu J., Zhou K., Shen K. Role of exocrine cells in pancreatic enhancement using Mn-DPDP-enhanced MR imaging. Chin Med J (Engl) 2002, 115:1363-1366.
79. Antkowiak P.F., Tersey S.A., Carter J.D., Vandsburger M.H., Nadler J.L., Epstein F.H., et al. Noninvasive assessment of pancreatic β-cell function in vivo with manganese-enhanced magnetic resonance imaging. Am J Physiol Endocrinol Metab 2009, 296:E573-E578.
80. 2+-responsive contrast agent. Proc Natl Acad Sci USA 2011, 108:18400-18405.
81. Van Belle T.L., Coppieters K.T., Von Herrath M.G. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011, 91:79-118.
82. Moore A., Bonner-Weir S., Weissleder R. Noninvasive in vivo measurement of β cell mass in mouse model of diabetes. Diabetes 2001, 50:2231-2236.